Atlas Trials

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Clinical trial NCT04460807 · TERMINATED

Trial details

NCT number
NCT04460807
Sponsor
Ente Ospedaliero Ospedali Galliera
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2020-02-13
Primary completion
2023-04-27
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.